Quote | Vincera Pharma Inc Com (NASDAQ:VINC)
Last: | $0.737 |
---|---|
Change Percent: | 1.22% |
Open: | $0.75 |
Close: | $0.737 |
High: | $0.7995 |
Low: | $0.73 |
Volume: | 275,234 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Vincera Pharma Inc Com (NASDAQ:VINC)
2024-05-15 06:46:03 ET More on Vincerx Pharma Vincerx Pharma dips 16%, prices $16M stock Vincerx Pharma announces proposed underwritten public offering of common stock and warrants Seeking Alpha’s Quant Rating on Vincerx Pharma Historical earnings data...
Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug conjugate (SMDC) The National Institutes of Health (NIH) and Vincerx announced positive result...
Message Board Posts | Vincera Pharma Inc Com (NASDAQ:VINC)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $VINC 58% v3,6M c1.08 f21,19M H1.13 ML.6311 | znewcar1 | investorshangout | 12/13/2022 10:27:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Vincera Pharma Inc Com Company Name:
VINC Stock Symbol:
NASDAQ Market:
Vincera Pharma Inc Com Website:
Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug conjugate (SMDC) The National Institutes of Health (NIH) and Vincerx announced positive result...
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 6,000,000 shares of common stock,...
PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of shares of its common stock and accompanying common stock warrants to purchase shares of its common stock and, to certain investors, pre-funded warra...